Carboxyl-terminal blockade of sortilin binding enhances progranulin gene therapy in a mouse model of frontotemporal dementia | Science Translational Medicine
The effectiveness of progranulin gene therapy in FTD models is improved by blocking the protein’s carboxyl terminus, which prevents sortilin binding.
